| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.04 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.05 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.05 |